CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to HUMA

Acellular Tissue Engineered Vessel (ATEV)

Phase 3
Humacyte, Inc. (HUMA)

Phase 3

Development Phase

1

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Upcoming Catalysts
What are catalysts?
Jun '27
HUMAPhase 3

Acellular Tissue Engineered Vessel (ATEV) Phase 3 Est. Readout

Acellular Tissue Engineered Vessel (ATEV)
Jun 2027~
CT.gov
00%
Competitive Landscape

1 competitor in End Stage Renal Disease (ESRD)

View Full Landscape
Drug Information

Target Indication

End Stage Renal Disease (ESRD)

Clinical Trial

NCT05908084

Last updated: 12/19/2025

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.